Valuation: Enzo Biochem, Inc.

Capitalization 35.66M 30.6M 28.51M 26.52M 48.94M 3.07B 54.64M 344M 130M 1.44B 134M 131M 5.29B P/E ratio 2023
3.59x
P/E ratio 2024 -2.23x
Enterprise value -13.2M -11.33M -10.55M -9.82M -18.12M -1.14B -20.23M -128M -48.13M -533M -49.52M -48.5M -1.96B EV / Sales 2023
-0.06x
EV / Sales 2024 0.31x
Free-Float
79.05%
Yield 2023 *
-
Yield 2024 8.77%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.24%
1 week+0.24%
Current month+0.55%
1 month+26.26%
3 months+113.03%
6 months+0.92%
Current year-4.56%
More quotes
1 week 0.68
Extreme 0.68
0.68
1 month 0.51
Extreme 0.51
0.68
Current year 0.25
Extreme 0.252
0.76
1 year 0.25
Extreme 0.252
1.19
3 years 0.25
Extreme 0.252
2.75
5 years 0.25
Extreme 0.252
4.85
10 years 0.25
Extreme 0.252
12.04
More quotes
Manager TitleAgeSince
Chief Executive Officer 57 2023-09-04
Director of Finance/CFO 48 -
Chief Tech/Sci/R&D Officer 61 2014-06-30
Director TitleAgeSince
Director/Board Member 57 2024-01-30
Director/Board Member 51 2022-01-02
Chairman 65 2023-10-25
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.24%+0.24%-39.67%-73.68% 35.66M
+3.62%+6.18%-16.44%-13.99% 77.97B
-1.36%-4.44%-49.17%-7.53% 58.12B
-1.78%+5.10%+23.50%+28.64% 54.74B
+0.49%+1.30%+23.57%+109.40% 38.32B
-0.06%+10.97%+116.40%+141.66% 19.41B
-2.88%-6.87%-44.51%-41.69% 18.86B
+0.31%+9.13%+78.83%+804.62% 18.77B
-0.04%-.--%+72.36%+138.68% 14.02B
-1.57%-1.06%+3.81%-13.95% 13.34B
Average -0.22%+1.90%+16.87%+107.22% 31.36B
Weighted average by Cap. +0.22%+1.56%+6.42%+73.50%
See all sector performances

Financials

2023 2024
Net sales 31.06M 26.65M 24.83M 23.1M 42.63M 2.68B 47.59M 300M 113M 1.25B 117M 114M 4.61B 31.91M 27.38M 25.51M 23.73M 43.79M 2.75B 48.89M 308M 116M 1.29B 120M 117M 4.74B
Net income 20.29M 17.41M 16.22M 15.09M 27.84M 1.75B 31.09M 196M 73.96M 819M 76.1M 74.52M 3.01B -26.08M -22.37M -20.85M -19.4M -35.79M -2.25B -39.96M -252M -95.07M -1.05B -97.82M -95.79M -3.87B
Net Debt -75.38M -64.67M -60.26M -56.06M -103M -6.49B -115M -728M -275M -3.04B -283M -277M -11.19B -48.86M -41.92M -39.06M -36.34M -67.05M -4.21B -74.87M -472M -178M -1.97B -183M -179M -7.25B
More financial data * Estimated data
Logo Enzo Biochem, Inc.
Enzo Biochem, Inc. is a global life science company. The Company's primary business is conducted through its Life Sciences division, Enzo Life Sciences, which is focused on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of products, including antibodies, genomic probes, assays, biochemicals, and proteins. Its products are used to label, detect and visualize a biological target of interest in drug discovery exploration and drug development process development. The Company’s proprietary products and technologies play central roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The Company monetizes its technology primarily via sales through its global distribution network and licensing. The Company conducts its research and other product development efforts through internal research and collaborative relationships.
Employees
131
More about the company
Date Price Change Volume
25-07-18 0.6817 $ +0.24% 3,011
25-07-17 0.6801 $ 0.00% 85,447
25-07-16 0.6801 $ -0.43% 17,186
25-07-15 0.6830 $ +0.08% 9,721
25-07-14 0.6825 $ +0.35% 201,955

Delayed Quote OTC Markets, July 18, 2025 at 03:15 pm

More quotes